NCT06726304

Brief Summary

The goal of this randomized controlled pilot trial is to evaluate the feasibility, acceptability, and clinical utility of a baby carrier intervention aimed at improving maternal sensitivity and mother-infant bonding in prenatally anxious/depressed mothers. The study has three main questions:

  1. 1.Is the intervention feasible (e.g., enrollment and recruitment rates) and acceptable to participants (e.g., compliance and perceived benefits)?
  2. 2.Does the intervention improve maternal sensitivity compared to a waitlist control group?
  3. 3.Does the intervention increase mother-infant neural synchrony compared to a waitlist control group, measured using functional near-infrared spectroscopy?

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
13mo left

Started Feb 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Feb 2025May 2027

First Submitted

Initial submission to the registry

December 1, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 10, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

February 12, 2025

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2027

Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

2.2 years

First QC Date

December 1, 2024

Last Update Submit

April 22, 2026

Conditions

Keywords

baby carriermaternal sensitivityinter-personal neural synchronyperinatal anxietyperinatal depression

Outcome Measures

Primary Outcomes (1)

  • Feasibility: Proportion of Eligible Participants Successfully Enrolled and Retained Over 12 Months

    To assess the feasibility of the baby carrier intervention, including recruitment, enrollment, and retention rates, using the ratio of eligible versus enrolled participants and enrolled versus retained participants.

    From the beginning of recruitment to the end of the last assessment (at 16 weeks postpartum)

Secondary Outcomes (1)

  • Acceptability: Adherence to the baby carrier intervention

    From the beginning of the intervention (at 8 weeks postpartum) to the end of the intervention (up until 16 weeks postpartum)

Other Outcomes (3)

  • Utility of the baby carrier intervention

    From baseline assessment (at week 8) to final assessment (at week 16) of maternal sensitivity

  • Inter-personal Neural Synchrony

    During the second home visit (at week 16 postpartum)

  • Qualitative Analysis of Maternal Experiences with Babywearing

    During the second home visit (at week 16 postpartum)

Study Arms (2)

Baby Carrier Intervention Group

EXPERIMENTAL

Participants and their babies will be visited twice by trained research staff in their home. Once at the beginning of the study (at 8 weeks postpartum) and for a second time at the end of the study (at 16 weeks postpartum). During the first visit, mothers will choose between two soft ergonomic baby carriers and be given instructions regarding the expected frequency and length of usage. Maternal sensitivity will be observed during a 15-minute free play session of the mother-baby dyad. During the second home visit, inter-personal neural synchrony in mother-baby dyads will be assessed during a joint attention task (9 minutes). Participants will also be interviewed about their lived experiences with babywearing and increased physical contact with their baby (30-40 minutes). Finally, participants will complete questionnaires about mother-infant bonding, depression and anxiety symptoms, and rate the burden of the protocol.

Behavioral: Baby Carrier Intervention

Waitlist Control Group

NO INTERVENTION

The waitlist control group will be assessed using the same measures as the intervention group (described above) except for the open-ended interview questions about their lived experiences with regular babywearing and increased physical contact with their baby. At the end of the second home visit, all waitlist control participants will be offered to choose between the same two ergonomic baby carrier models as the intervention group, and will be provided with the same instructions regarding the recommended frequency and length of use as intervention group participants at the beginning of the study.

Interventions

Mothers in the intervention group will have the opportunity to choose between two different soft ergonomic baby carriers and will receive instructions on how to use the carrier of their choice. Infants will be placed chest-to-chest in the carrier, supported by the mother's upper torso for a prescribed amount of time during the period of six weeks.

Baby Carrier Intervention Group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • be able to communicate in English or French
  • diagnosed with a depressive or anxiety disorder (or both) during their intake visit within the Perinatal Multisite Databank (PMD)
  • residing in the greater Montreal area
  • have given birth to a healthy baby

You may not qualify if:

  • having known alcohol or substance use issues,
  • having been diagnosed with psychosis or schizophrenia during the PMD intake assessment, or have had thoughts of harming the self or the baby
  • having physical restrictions that may prevent the regular use of a baby carrier
  • taking any medications regularly that cause potential participants to feel drowsy or dizzy
  • already using a baby carrier with their current baby for more than 5 hours a week

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lady Davis Institute of the Jewish General Hospital

Montreal, Quebec, H3T 1E2, Canada

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Behavioural intervention with rolling recruitment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Co-Principal Investigator

Study Record Dates

First Submitted

December 1, 2024

First Posted

December 10, 2024

Study Start

February 12, 2025

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

May 31, 2027

Last Updated

April 28, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations